Jul 22, 2026 01:00AM
Jul 22, 2026 01:00AM
Jul 22, 2026 01:00AM
May 6, 2025 01:30AM
Apr 24, 2024 01:00AM
Oct 23, 2023 01:00AM
Jul 21, 2023 08:52AM Correction: Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome  
Jul 21, 2023 07:52AM
Apr 27, 2023 01:00AM
Mar 2, 2023 02:13PM
Feb 22, 2023 01:00AM
Feb 15, 2023 01:00AM
Feb 9, 2023 01:00AM
Jan 9, 2023 01:00AM Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases
Oct 27, 2022 12:57AM
Aug 12, 2022 11:35AM
Aug 5, 2022 01:00AM
Jul 28, 2022 12:57AM
Jun 29, 2022 01:00AM
Jun 27, 2022 01:01AM
Jun 27, 2022 01:00AM Ipsen to Acquire Epizyme, Expanding Its Portfolio in Oncology
May 24, 2022 01:00AM
Feb 11, 2022 01:00AM
Jan 24, 2022 01:00AM
Aug 13, 2021 01:00AM
Jul 29, 2021 01:00AM
May 28, 2021 01:49PM
May 27, 2021 01:00AM Ipsen: Description of the Regulatory Framework of the Share Repurchase Program Proposed by the Board of Directors to Be Approved at the Combined Shareholders’ Meeting on 27 May 2021 (17th resolution
Apr 22, 2021 01:00AM
Apr 1, 2021 04:15PM
Mar 2, 2021 07:39AM
Mar 2, 2021 07:30AM
Feb 11, 2021 12:58AM
Sep 14, 2020 01:00AM
Sep 10, 2020 01:00AM Ipsen to Present New Insights at ASBMR for Potential Treatment of Ultra-rare Disease Fibrodysplasia Ossificans Progressiva (FOP), Including Global Phase III MOVE Trial Results
Aug 25, 2020 01:00AM
Jul 30, 2020 01:00AM
Jun 8, 2020 01:00AM
May 29, 2020 01:05AM
May 29, 2020 01:00AM
May 4, 2020 01:00AM
Mar 26, 2020 02:00AM Ipsen Provides Update on Palovarotene Clinical Programs
Feb 13, 2020 01:00AM
Jan 24, 2020 01:00AM
Oct 16, 2019 01:00AM
Sep 26, 2019 01:00AM
Jul 25, 2019 01:00AM
May 28, 2019 01:30AM
May 24, 2019 01:00AM New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting
May 14, 2019 01:00AM

1,171,128 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All